ELOXX PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -298.1% | -194.1% | -147.8% |
| FY2022 | 338.3% | 1,714.9% | -170.7% |
| FY2023 | 75.5% | 81.3% | -996.1% |
| FY2024 | 12.9% | 12.9% | -105.6% |
| FY2025 | 50.3% | 50.3% | -113.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -298.1% | -194.1% | -147.8% |
| FY2022 | 338.3% | 1,714.9% | -170.7% |
| FY2023 | 75.5% | 81.3% | -996.1% |
| FY2024 | 12.9% | 12.9% | -105.6% |
| FY2025 | 50.3% | 50.3% | -113.8% |